Intravitreal ranibizumab for persistent diabetic vitreous haemorrhage: a randomised, double-masked, placebo-controlled feasibility study.

Robert Petrarca Cristina SoareRoger WongRiti DesaiJames NeffendorfAndrew SimpsonTimothy L Jackson

Published in: Acta ophthalmologica (2019)

Intravitreal ranibizumab may reduce the likelihood of proceeding to vitrectomy in patients with persistent, dense diabetic vitreous haemorrhage. Further studies appear feasible and justified.

Keyphrases

diabetic retinopathy
age related macular degeneration
placebo controlled
double blind
optical coherence tomography
type diabetes
wound healing
clinical trial
study protocol
vascular endothelial growth factor
open label
phase ii
phase iii
squamous cell carcinoma
case control
locally advanced